Intrauterine infection with parvovirus B19 and CMV: implications in early and late gestation fetal demise

References

• Martin J, Hoyert D. The national fetal death file. Semin. Perinatol. 26(1), 3–11 (2002).
   PubMed Web of Science ®Google Scholar
• Frøen F, Arnestad M, Frey K, Vege A, Didrik Saugstad O, Stray-Pedersen B. Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986–1995. Am. J. Obstet. Gynecol. 184, 694–702 (2001).
   PubMed Web of Science ®Google Scholar
• Cnattingius S, Stephansson O. The epidemiology of stillbirth. Semin. Perinatol. 26(1), 25–30 (2002).
   PubMed Web of Science ®Google Scholar
• Fretts RC, Boyd ME, Usher RH et al. The changing pattern of fetal death, 1961–1988. Obstet. Gynecol. 79(1), 35–39 (1992).
   PubMed Web of Science ®Google Scholar
• Goffinet F, Combier E, Bucourt M, de Caunes F, Papiernik E. Epidemiology of antepartum stillbirth in the Seine-Saint-Denis Perinatal Survey. J. Gynecol. Obstet. Biol. Reprod. 26, 153–159 (1996).
   Google Scholar
• Weeks JW, Asrat T, Morgan MA, Nageotte M, Thomas SJ, Freeman RK. Antepartum surveillance for a history of stillbirth: when to begin? Am. J. Obstet. Gynecol. 172, 486–492 (1995).
   PubMedGoogle Scholar
• Embleton ND. Fetal and neonatal death from maternally acquired infection. Paed. Perinat. Epidemiol. 15, 54–60 (2001).
   PubMedGoogle Scholar
• Moyo SR, Hagerstrand I, Nystrom L et al. Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings. Int. J. Gynaecol. Obstet. 54(2), 115–123 (1996).
   PubMedGoogle Scholar
• Gibbs RS. The origins of stillbirth: infectious diseases. Semin. Perinatol. 26(1), 75–78 (2002).
   PubMed Web of Science ®Google Scholar
• Horn LC, Rose I. Placental and fetal pathology in intrauterine viral infections. Intervirology 41, 219–225 (1998).
   PubMedGoogle Scholar
• Yankowitz J, Weiner CP, Henderson J, Grant S, Towbin JA. Outcome of low-risk pregnancies with evidence of intraamniotic viral infection detected by PCR on amniotic fluid obtained at second trimester genetic amniocentecis. J. Soc. Gynecol. Invest. 3, 132A (1996).
   Google Scholar
• Ignatia B, Van den Veyver LB, Ni J et al. Detection of intrauterine viral infection using the polymerase chain reaction. Mol. Gen. Metabol. 63, 85–95 (1998).
   PubMedGoogle Scholar
• Wenstrom KD, Andrews WW, Bowles NE, Towbin JA, Hauth JC, Goldenberg RL. Intrauterine viral infection at the time of second trimester genetic amniocentecis. Obstet. Gynecol. 92, 420–424 (1998).
   PubMed Web of Science ®Google Scholar
• Redline RW. Placental inflammation. Semin. Neonatol. 9(4), 265–274 (2004).
   PubMedGoogle Scholar
• Eis-Hűbinger AM, Dieck D, Schild R, Hansmann M, Schneweis KE. Parvovirus B19 infection in pregnancy. Intervirology 41, 178–184 (1998).
   PubMedGoogle Scholar
• Kyriazopoulou V, Simitsopoulou M, Bondis J et al. Human parvovirus B19: immunity of Greek females and prenatal investigation of hydrops fetalis. Eur. J. Obstet. Gynecol. Reprod. Biol. 74, 157–160 (1997).
   PubMedGoogle Scholar
• Valeur-Jensen AK, Pedersen CB, Westergaard T et al. Risk factors for parvovirus B19 infection in pregnancy. J. Am. Med. Assoc. 281(12), 1099–1105 (1999).
   PubMed Web of Science ®Google Scholar
• Gilbert GL. Parvovirus B19 infection and its significance in pregnancy. Commun. Dis. Intel. 24(Suppl.), S69–S71 (2000).
   PubMedGoogle Scholar
• Yaegashi N, Niinuma T, Chisaka H et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection:report of 10 cases and meta-analysis. J. Infect. 37, 28–35 (1998).
   PubMed Web of Science ®Google Scholar
• Gratacós E, Torres P-J, Vidal J et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis. 171, 1360–1363 (1995).
   PubMed Web of Science ®Google Scholar
• Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B19 during pregnancy: a review. Obstet. Gynecol. Surv. 52(4), 254–259 (1997).
   Google Scholar
• Saldanha J, Minor P. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficacy and consistency of removal of B19 DNA during manufacture. Br. J. Haematol. 93, 7141–7149 (1996).
   Google Scholar
• Cohen BJ, Beard S, Knowles WA et al. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 37, 947–952 (1997).
   PubMedGoogle Scholar
• Heegaard ED, Brown KE. Human parvovirus B19. Clin. Microbiol. Rev. 15(3), 485–505 (2002).
   PubMed Web of Science ®Google Scholar
• Plachouras N, Stefanidis K, Andronikou S, Lolis D. Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A case report. J. Reprod. Med. 44(4), 377–380 (1999).
   PubMedGoogle Scholar
• Schild RL, Plath H, Thomas P, Schulte-Wissermann H, Eis-Hubinger A, Hansmann M. Fetal parvovirus B19 infection and meconium peritonitis. Fetal Diagn. Ther. 13, 15–18 (1998).
   PubMed Web of Science ®Google Scholar
• Miyagawa S, Takahashi Y, Nagai A et al. Angio-oedema in a neonate with IgG antibodies to parvovirus B19 following intrauterine parvovirus B19 infection. Br. J. Dermatol. 143, 428–430 (2000).
   PubMedGoogle Scholar
• Isumi H, Nunoue T, Nishida A, Takashima S. Fetal brain infection with human parvovirus B19. Pediatr. Neurol. 21, 661–663 (1999).
   PubMed Web of Science ®Google Scholar
• Katz VL, McCoy MC, Kuller JA, Hansen W. An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. J. Perinatol. 13(1), 43–45 (1996).
   Google Scholar
• Simchen MJ, Toi A, Bona M, Alkazaleh F, Ryan G, Chitayat D. Fetal hepatic calcifications: prenatal diagnosis and outcome. Am. J. Obstet. Gynecol. 187, 1617–1622 (2002).
   PubMed Web of Science ®Google Scholar
• Metzman R, Anand A, DeGiulio PA, Knisely AS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J. Pediatr. Gastroenterol. Nutr. 9, 112–114 (1989).
   PubMed Web of Science ®Google Scholar
• O’Malley A, Barry-Kinsella C, Hughes C et al. Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr. Dev. Pathol. 6, 414–420 (2003).
   PubMedGoogle Scholar
• Dembinski J, Eis-Hubinger AM, Maar J, Schild R, Bartmann P. Long term follow up of serostatus after maternofetal parvovirus B19 infection. Arch. Dis. Child. 88, 219–221 (2003).
   PubMed Web of Science ®Google Scholar
• Bendon RW. Review of some causes of stillbirth. Pediatr. Dev. Pathol. 4, 517–531 (2001).
   PubMed Web of Science ®Google Scholar
• Yaegashi N, Niinuma T, Chisaka H et al. Serologic study of human parvovirus B19 infection in pregnancy in Japan. J. Infect. 38, 30–35 (1999).
   PubMed Web of Science ®Google Scholar
• Von Kaisenberg CS, Jonat W. Fetal parvovirus B19 infection. Ultrasound Obstet. Gynecol. 18, 280–288 (2001).
   PubMed Web of Science ®Google Scholar
• Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection, time in gestation, viral persistence and fetal prognosis. Pediatr. Infect. Dis. J. 21, 1133–1136 (2002).
   PubMed Web of Science ®Google Scholar
• Tolfvenstam T, Papadogiannakis N, Norbeck O, Peterson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 357, 1494–1497 (2001).
   PubMed Web of Science ®Google Scholar
• Wright C, Hinchliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br. J. Obstet. Gynaecol. 103, 133–136 (1996).
   PubMedGoogle Scholar
• Saito S. Cytokine cross-talk between mother and the embryo/placenta. J. Reprod. Immunol. 52, 15–33 (2001).
   PubMedGoogle Scholar
• Lowden E, Weinstein L. Unexpected second trimester pregnancy loss due to maternal parvovirus B19 infection. South. Med. J. 90(7), 702–704 (1997).
   PubMedGoogle Scholar
• Skoldebrand-Sparre L, Tolfvenstam T, Papadogianakis N, Wahren B, Broliden K, Nyman M. Parvovirus B19 infection: association with third-trimester intrauterine fetal death. Br. J. Obstet. Gynaecol. 107, 476–480 (2000).
   Google Scholar
• Norbeck O, Papadogiannakis N, Petersson K, Hirbord T, Broliden K, Tolfvenstam T. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin. Infect. Dis. 35, 1032–1038 (2002).
   PubMed Web of Science ®Google Scholar
• Cohen BJ, Bates CN. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J. Virol. Methods 55, 11–25 (1995).
   PubMedGoogle Scholar
• Koch WC, Harger JH, Barnstein B, Adler SP. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr. Infect. Dis. J. 17, 489–494 (1998).
   PubMedGoogle Scholar
• Trotta M, Azzi A, Meli M et al. Intrauterine parvovirus B19 infection: early prenatal diagnosis is possible. Int. J. Infect. Dis. 8(2), 130–131 (2004).
   PubMedGoogle Scholar
• Wermelinger MC, Oelemann WM, Lima de Mendonca MC, Naveca FG, von Hubinger MG. Detection of human parvovirus B19 infection: a study of 212 suspected cases in the state of Rio de Janeiro, Brazil. J. Clin. Virol. 25, 223–230 (2002).
   PubMed Web of Science ®Google Scholar
• Sohan K, Carroll S, Byrne D, Ashworth M, Soothill P. Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester. Fetal Diagn. Ther. 15, 234–236 (2000).
   PubMedGoogle Scholar
• Giannakopoulou CH, Hatzidaki E, Giannakopoulos K et al. Congenital infection by human parvovirus B19 ascites-anaemia. Clin. Exp. Obstet. Gynecol. 25, 92–93 (1998).
   PubMedGoogle Scholar
• Cosmi E, Mari G, Delle Chiaie L et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am. J. Obstet. Gynecol. 187, 1290–1293 (2002).
   PubMed Web of Science ®Google Scholar
• Hernandez-Andrade E, Scheier M, Dezerega V, Carmo A, Nicolaides K. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops. Ultrasound Obstet. Gynecol. 23, 442–445 (2004).
   PubMed Web of Science ®Google Scholar
• Bodéus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet. Gynecol. 93, 658–660 (1999).
   PubMed Web of Science ®Google Scholar
• Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J. Infect. Dis. 186, 553–557 (2002).
   PubMed Web of Science ®Google Scholar
• Gabrielli L, Lazzarotto T, Foschini MP et al. Horizontal in utero acquisition of cytomegalovirus infection in a twin pregnancy. J. Clin. Microbiol. 41(3), 1329–1331 (2003).
   PubMedGoogle Scholar
• Ahlfors K, Ivarsson S-A, Harris S. Report on a long term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand. J. Infect. Dis. 31, 443–457 (1999).
   PubMedGoogle Scholar
• Gouarin S, Palmer P, Cointe D et al. Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR. J. Clin. Virol. 21, 47–55 (2001).
   PubMed Web of Science ®Google Scholar
• Guerra B, Lazzarotto T, Quarta S et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am. J. Obstet. Gynecol. 183, 476–482 (2000).
   PubMed Web of Science ®Google Scholar
• Stagno S, Pass RF, Dworsky ME et al. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N. Engl. J. Med. 306, 945 (1982).
   PubMed Web of Science ®Google Scholar
• Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344, 1366–1371 (2001).
   PubMed Web of Science ®Google Scholar
• Saigal S, Lunyk O, Larke RPB, Chernesky MA. The outcome in children with congenital cytomegalovirus infection. Am. J. Dis. Child. 136, 896–901 (1982).
   PubMedGoogle Scholar
• Griffiths PD, Baboonian C. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br. J. Obstet. Gynaecol. 91, 307–315 (1984).
   PubMedGoogle Scholar
• Wen LZ, Xing W, Liu LQ, Ao LM, Chen SH, Zeng WJ. Cytomegalovirus infection in pregnancy. Int. J. Gynecol. Obstet. 79(2), 111–116 (2002).
   PubMed Web of Science ®Google Scholar
• Murph JR, Souza IE, Dawson JD et al. Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am. J. Epidemiol. 147(10), 940–947 (1998).
   PubMedGoogle Scholar
• Pass RF. Cytomegalovirus. In: Principles and Practice of Paediatric Infectious Diseases (Second Edition). Long SS, Pickering LK, Prober CG (Eds), Churchill Livingstone, PA, USA, 1050–1059 (2003).
   Google Scholar
• Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J. Virol. 74(15), 6808–6820 (2000).
   PubMed Web of Science ®Google Scholar
• Michelson S. Human cytomegalovirus escape from immune detection. Intervirology 42, 301–307 (1999).
   PubMedGoogle Scholar
• Chan G, Hemmings DG, Yurochko AD, Guillbert LJ. Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early-gene-induced tumor necrosis factor-α. Am. J. Pathol. 161(4), 1371–1381 (2002).
   PubMed Web of Science ®Google Scholar
• Harrison CJ, Caruso N. Correlation of maternal and pup NK-like activity and TNF responses against cytomegalovirus to pregnancy outcome in inbred guinea pigs. J. Med. Virol. 60, 230–236 (2000).
   PubMedGoogle Scholar
• Hemmings DG, Kilani R, Nykiforuk C, Preiksaitis J, Guilbert LJ. Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J. Virol. 72(6), 4970–4979 (1998).
   PubMedGoogle Scholar
• Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J. Clin. Virol. 29(2), 71–83 (2004).
   PubMed Web of Science ®Google Scholar
• Pereira L, Maidji E, McDonagh S, Genbacev O, Fisher S. Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J. Virol. 77(24), 13301–13314 (2003).
   PubMed Web of Science ®Google Scholar
• Gharavi AE, Vega-Ostertag M, Espinola RG et al. Intrautrine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies. Lupus 13, 17–23 (2004).
   PubMed Web of Science ®Google Scholar
• Lanari M, Lazzarotto T, Papa I et al. Neonatal aortic arch thrombosis as a result of congenital cytomegalovirus infection. Pediatrics 108(6), 114 (2001).
   Google Scholar
• Nigro G, La Torre R, Sali E et al. Intraventricular haemorrhage in a fetus with cerebral cytomegalovirus infection. Prenat. Diagn. 22, 558–561 (2002).
   PubMed Web of Science ®Google Scholar
• Riley HD Jr. History of the cytomegalovirus. Southern Med. J. 90, 184–190 (1997).
   PubMedGoogle Scholar
• Ozono K, Mushiake S, Takeshima T, Nakayama M. Diagnosis of congenital cytomegalovirus infection by examination of pacenta: application of polymerase chain reaction and in situ hybridization. Pediatr. Pathol. Lab. Med. 17, 249–258 (1997).
   PubMedGoogle Scholar
• Nelson CT, Demmler GJ. Cytomegalovirus infection in the pregnant mother, fetus and newborn infant. Clin. Perinatol. 24(1), 151–160 (1997).
   PubMed Web of Science ®Google Scholar
• Lipitz S, Achiron R, Zalel Y et al. Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet. Gynecol. 100, 428–433 (2002).
   PubMedGoogle Scholar
• Lipitz S, Yagel S, Shalev E, Achiron R, Mashiach S, Schiff E. Prenatal diagnosis of fetal primary cytomegalovirus infection. Obstet. Gynecol. 89(5), 763–767 (1997).
   PubMed Web of Science ®Google Scholar
• Nigro G, Mazzocco M, Anceschi MM, La Torre R, Antonelli G, Cosmi EV. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet. Gynecol. 94(6), 909–914 (1999).
   PubMed Web of Science ®Google Scholar
• Inoue T, Matsumura N, Fukuoka M, Sagawa N, Fujii S. Severe congenital cytomegalovirus infection with fetal hydrops in a cytomegalovirs-seropositve healthy woman. Eur. J. Obstet. Gynecol. Reprod. Biol. 95, 184–186 (2001).
   PubMedGoogle Scholar
• Gaytant MA, Rours GI, Steegers EA, Galama JM, Semmekrot BA. Congenital cytmegalovirus infection after recurrent infection: case reports and review of the literature. Eur. J. Pediatr. 162, 248–253 (2003).
   PubMed Web of Science ®Google Scholar
• Brown HL, Abernathy MP. Cytomegalovirus infection. Semin. Perinatol. 22, 260–266 (1998).
   PubMed Web of Science ®Google Scholar
• Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J. Infect. Dis. 171, 1115–1121 (1995).
   PubMed Web of Science ®Google Scholar
• Ruellan–Eugene G, Barjot P, Campet M et al. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. J. Med. Virol. 50, 9–15 (1996).
   PubMed Web of Science ®Google Scholar
• Grangeot-Keros L, Mayaux MJ, Lebon P et al. Value of cytomegalovirus (CMV) avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis. 175, 944–946 (1997).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Varani S, Spezzacatena P et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol. 13, 137–141 (2000).
   PubMed Web of Science ®Google Scholar
• Hagay ZJ Biran G, Ornoy A, Reece A. Congenital cytomegalovirus infection: a long-standing problem still seeking a solution. Am. J. Obstet. Gynecol. 174, 241–245 (1996).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Guerra B, Spezzacatena P et al. Prenatal diagnosis of congenital cytomegalovirus infection. J. Clin. Microbiol. 36, 3540–3544 (1998).
   PubMed Web of Science ®Google Scholar
• Jones RN, Lynne Neale M, Beattie B, Westmoreland D, Fox JD. Development and application of a PCR-based method including an internal control for diagnosis of congenital cytomegalovirus infection. J. Clin. Microbiol. 38, 1–6 (2000).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J. Pediatr. 137, 90–95 (2000).
   PubMed Web of Science ®Google Scholar
• Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of cytomegalovirus infection in 189 pregnancies with known outcome. Prenat. Diagn. 21, 362–377 (2001).
   PubMed Web of Science ®Google Scholar
• Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J. Infect. Dis. 177, 1170–1175 (1998).
   PubMed Web of Science ®Google Scholar
• Rousseau T, Douvier S, Reynaud I et al. Severe fetal cytomegalic inclusion disease after documented maternal reactivation of cytomegalovirus infection during pregnancy. Prenat. Diagn. 20, 333–336 (2000).
   PubMedGoogle Scholar
• Gerdts V, Snider M, Brownlie R, Babiuk LA, Griebel PJ. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J. Immunol. 168, 1877–1885 (2002).
   PubMed Web of Science ®Google Scholar
• Pass RF, Duliege AM, Boppana S et al. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J. Infect. Dis. 180(4), 970–975 (1999).
   PubMed Web of Science ®Google Scholar
• Bansal GP, Hatfield JA, Dunn FE et al. Candidate recombinant vaccine for human B19 parvovirus. J. Infect. Dis. 167, 1034–1044 (1993).
   PubMed Web of Science ®Google Scholar